IGNITE Webinar 2024

November 14, 2024 | 2:00
ET

The NINDS IGNITE Program is a suite of early translational funding opportunities (NOFOs). This webinar will describe the program and give some tips for applying. The target audience is anyone interested in funding for translating novel small molecule or biologic therapeutics for neurological disorders.

Investigators interested in learning more about these exciting opportunities are encouraged to register and participate in this Q&A Webinar on Thursday, November 14, 2024, at 2 PM ET (US and Canada).

For further information, please contact Shruthi Thomas.

The following NOFOs will be discussed: 

  • Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
  • Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
  • Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

NINDS speakers for this webinar include: 

  • Rebecca Roof, PhD
  • Shardell Spriggs, PhD
  • Christopher Conrad, PhD
  • Shruthi Thomas, MS